pillbase.ru

Rybrevant

Active substance: amivantamab

INJECTION · AMIVANTAMAB 350 mg/1

United StatesActive

Marketing holder: Janssen Biotech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Рибревант
    концентрат для приготовления раствора для инфузий, 350 мг, 7 мл (original in Russian, GRLS)
    ЛП-№(014025)-(РГ-RU)
    ООО "Джонсон & Джонсон"
EU 1
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-dbb9-770c-a8f2-c525bdfd6071;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-f65e-7be4-84d3-01dcb734e8b3;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
57894-501
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 57894-501 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 57894-501 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 57894-501 · Verified 2026-10-09 · open in source